May 2026 | Efficient Nucleic Acid Delivery in Primary Cells
At RJH Biosciences, we develop non-viral, polymer-based nucleic acid delivery systems designed for efficient transfection of primary and hard-to-transfect cells. Our platform enables robust delivery
March 2026 | Delivery Insights: RJH Biosciences Contract Services
RJH Biosciences provides polymer-based transfection solutions supporting RNA and DNA delivery across cell lines, primary cells, and in vivo models. This edition highlights recent client
February 2026 | Advancing mRNA Delivery In Vivo: New Animal Study Results
Polymer-Based Solutions for Effective In Vivo mRNA Delivery At RJH Biosciences, we develop non-viral, polymer-based delivery platforms engineered for efficient and reproducible mRNA delivery across
January 2026 | Polymer-Based Solutions for Strong RNA and DNA Delivery Across Biological Systems
At RJH Biosciences, we develop non-viral, polymer-based transfection technologies optimized for delivery of nucleic acids across a wide range of modalities. Our platforms enable efficient
December 2025 | CRISP-Fect: A Polymer-Based Platform for Efficient CRISPR Genome Editing
Learn how our polymer-based transfection reagents enable CRISPR activity and open new possibilities for gene editing. Engineered for high-efficiency gene editing. GFP Knockout CRISP-Fect: Functional Knockout Validated
October 2025 | Proven In Vivo Performance for mRNA and siRNA Delivery
Strong mRNA expression and siRNA silencing across multiple organs demonstrate the superior performance and reliability of RJH’s delivery technology. Robust Multi-Organ mRNA Expression mRNA-Fect Ultra